Receptor Tyrosine Kinases as Therapeutic Targets the Model of the MET Oncogene

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|2|1|41-55

ISSN： 1389-4501

Source： Current Drug Targets, Vol.2, Iss.1, 2001-01, pp. : 41-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptor Tyrosine Kinases as Targets for Anticancer Therapeutics

By  

Current Medicinal Chemistry, Vol. 12, Iss. 15, 2005-07 ,pp. : 1773-1781

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of receptor tyrosine kinases in lung cancer

By Choong Nicholas W   Ma Patrick C   Salgia Ravi  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 533-559

Informa Healthcare

Access to resources Recommend Favorite

Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 205-216

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy

By  

Current Drug Targets, Vol. 4, Iss. 2, 2003-02 ,pp. : 113-121

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases and Anticancer Therapy

By  

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-04 ,pp. : 1139-1149

Bentham Science Publishers

Access to resources Recommend Favorite